IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0012878
(2001-11-02)
|
발명자
/ 주소 |
- Brown, Daniel P.
- Dean, Michael C.
- Wilson, Ross
- Grunauer, Gary
- Ahluwalia, Gurp
|
출원인 / 주소 |
- Flexible Products Company
|
대리인 / 주소 |
Vedder Price Kaufman & Kammholz
|
인용정보 |
피인용 횟수 :
5 인용 특허 :
12 |
초록
▼
A carton for a foam dispensing system which includes supply containers, a dispenser and hoses for connecting each container to the dispenser. The carton includes first and second face panels which are interconnected by respective first and second side panels. Bottom panels extend from the first and
A carton for a foam dispensing system which includes supply containers, a dispenser and hoses for connecting each container to the dispenser. The carton includes first and second face panels which are interconnected by respective first and second side panels. Bottom panels extend from the first and second face panels to define a bottom of the carton. The cover panel extends from the first face panel to define a cover of the carton. A first flap which is defined in the cover panel, which, in an open position, is disposed at an angle to the cover panel. A handle is connected to the containers for carrying the carton and projects through the first access opening. A second flap is defined in the second face panel and the first reinforcing element. A third flap is defined in the second flap. The hoses extend from the containers, through hose paths associated with the second flap to the dispenser.
대표청구항
▼
A carton for a foam dispensing system which includes supply containers, a dispenser and hoses for connecting each container to the dispenser. The carton includes first and second face panels which are interconnected by respective first and second side panels. Bottom panels extend from the first and
A carton for a foam dispensing system which includes supply containers, a dispenser and hoses for connecting each container to the dispenser. The carton includes first and second face panels which are interconnected by respective first and second side panels. Bottom panels extend from the first and second face panels to define a bottom of the carton. The cover panel extends from the first face panel to define a cover of the carton. A first flap which is defined in the cover panel, which, in an open position, is disposed at an angle to the cover panel. A handle is connected to the containers for carrying the carton and projects through the first access opening. A second flap is defined in the second face panel and the first reinforcing element. A third flap is defined in the second flap. The hoses extend from the containers, through hose paths associated with the second flap to the dispenser. ht of about 300 to about 2,000. 9. The process of claim 1, wherein B)(1) said organic compound containing at least two aromatic amine groups has a molecular weight of about 100 to about 400. 10. The process of claim 1, wherein B)(1) said organic compound containing aromatic amine groups has a functionality of about 2 and a molecular weight of about 150 to about 250. 11. The process of claim 1, wherein B)(1) said aromatic diamines are free of ether groups and/or ester groups. 12. The process of claim 1, wherein B)(1) said organic compound containing aromatic amine groups comprises an amine-terminated polyether wherein the amine-terminating groups are aromatic amine groups. 13. The process of claim 1, wherein B)(1) is selected from the group consisting of an isomer of diethyltoluenediamine, a mixture of isomers of diethyltoluenediamine, an isomer of dimethylthiotoluenediamine, and a mixture of isomers of dimethylthiotoluenediamine. 14. The process of claim 1, wherein B)(2) said organic compound having at least two hydroxyl groups has a molecular weight of 62 to 4,000. 15. The process of claim 1, wherein B)(2) said organic compound having at least two hydroxyl groups has a functionality of about 3 or less. 16. The process of claim 1, wherein B)(2) said organic compound having at least two hydroxyl groups comprises a low molecular weight glycol. 17. The process of claim 16, wherein said low molecular weight glycol has a molecular weight less than 500. 18. The process of claim 17, wherein said low molecular weight glycol has a molecular weight of less than 300. 19. The process of claim 1, wherein B)(2) said organic compound having at least two hydroxyl groups comprises a high molecular weight polyol. 20. The process of claim 19, wherein said high molecular weight polyol has a molecular weight greater than 500. 21. The process of claim 20, wherein said high molecular weight polyol has a molecular weight greater than 800. 22. The process of claim 21, wherein said high molecular weight polyol has a molecular weight greater than 1000. 23. The process of claim 1, wherein B)(2) said organic compound having at least two hydroxyl groups comprises a mixture of a glycol and a polyol. 24. The process of claim 1, wherein C) said organometallic catalyst comprises a tin catalyst. 25. The process of claim 24, wherein said tin catalyst comprises an organic tin(IV) catalyst. 26. The process of claim 24, wherein said organic tin catalyst is selected from the group consisting of dibutyltin dilaurate, dimethyltin dilaurate and mixtures thereof. 27. The process of claim 1, wherein said elastomer is post cured after demolding for at least 8 hours at a temperature of at least about 100° C. 28. The process of claim 1, wherein said component A) a liquid polyisocyanate or polyisocyanate prepolymer has an NCO group content of at least 5% and wherein said component A) a (cyclo)aliphatic polyisocyanate prepolymer has a monomer diisocyanate content of at least 10%. 29. The process of claim 1, wherein said polyisocyanate or polyisocyanate prepolymer has a viscosity of less than 1,000 mPa.s at 25° C. f phosgene and aqueous base into a mixture of mono- and bisphenol chloroformates which are then treated with a catalyst, additional aqueous caustic and a monophenol to afford endcapped polycarbonates. At relatively high levels of added monophenol endcapped polycarbonate oligomers are obtained. The method is especially suited for the continuous preparation of endcapped oligomers of tetrabromobisphenol A polycarbonate. The method is characterized by efficient use of phosgene, and conversion of chloroformate groups to carbonate linkages aided by trialkylamine catalysts bearing at least one methyl group on nitrogen, such as N,N-dimethylbutylamine (DMBA). substituted or substituted fused aryl or heterocycle. 5. A method for treating a disease associated with altered mitochondrial function comprising administering to an animal in need thereof an effective amount of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having the structure: or a stereoisomer, prodrug or pharmaceutically acceptable salt thereof, wherein R1,R2,R3,R4and R5are the same or different and individually hydrogen, halogen, hydroxy, alkyl, alkoxy, substituted alkyl, aryl, substituted aryl, arylalky, substituted arylalkyl, heterocycle, substituted heterocycle, heterocyclealkyl or substituted heterocyclealkyl; or R3taken together with R4,or R4taken together with R5,and further taken together with the respective carbon atom to which these groups are attached, form an unsubstituted or substituted fused aryl or heterocycle. 6. The method of any one of claims 4 or 5 wherein R1is hydrogen or alkyl. 7. The method of any one of claims 4 or 5 wherein R1is methyl. 8. The method of any one of claims 4 or 5 wherein R2is hydrogen, halogen, alkoxy, alkyl or substituted alkyl. 9. The method of any one of claims 4 or 5 wherein R2is hydrogen. 10. The method of any one of claims 4 or 5 wherein R3is hydrogen, halogen, hydroxy, alkoxy or alkyl. 11. The method of any one of claims 4 or 5 wherein R3is heterocycle. 12. The method of any one of claims 4 or 5 wherein R3is morpholinyl. 13. The method of any one of claims 4 or 5 wherein R4is hydrogen or alkoxy. 14. The method of any one of claims 4 or 5 wherein R5is hydrogen. 15. The method of any one of claims 4 or 5 wherein R4taken together with R5,and further taken together with the respective carbon atom to which these groups are attached, form an unsubstituted or substituted fused phenyl group. 16. The method of any one of claims 4 or 5 wherein R2,R4and R5are hydrogen. 17. The method of any one of claims 4 or 5 wherein R1is methyl and R3is hydroxy. UP>R9,R10,R11,R12,R13and R14independently represent hydrogen or C1 to 4 alkyl; or a pharmaceutically acceptable salt thereof. 2. A compound according to claim 1 wherein X represents a bond. 3. A compound according to claim 1 or claim 2, wherein R1represents chloro and m is 1. 4. A compound according to any one of claims 1 to 3, wherein Z represents NR6R7. 5. A compound according to any one of the preceding claims, wherein Y represents CH2. 6. A compound according to any one of the preceding claims, wherein each R5represents hydrogen. 7. A compound of formula (I), or a pharmaceutically acceptable salt thereof, according to claim 1 being selected from: 4-chloro-2-[2-(dimethylamino)-2-oxoethoxy]-N-[2-(4-phenethyl-1-piperazinyl)ethyl]benzamide;
※ AI-Helper는 부적절한 답변을 할 수 있습니다.